跳至主要内容
临床试验/EUCTR2020-001659-42-ES
EUCTR2020-001659-42-ES进行中(未招募)1 期

Pilot study of antithrombin as prophylaxis of acute respiratory distress syndrome in patients with COVID-19

Fundación para la Investigación Biomédica de Córdoba0 个研究点目标入组 46 人开始时间: 2020年4月20日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
46

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Age = 18 and <85 years
  • 2. Diagnosis confirmed by COVID-19 PCR
  • 3. Radiological image compatible with COVID-19
  • 4. Present any of the following clinical-functional criteria considered RISK:
  • 4.a. Respiratory distress: Tachypnea> 26 breaths / minute
  • 4. b. PaO2 / FiO2 oxygenation index = 300
  • 4.c. Alteration of one or more of the following parameters:
  • 4.c.i. DD> 1,000 µg / L
  • 4.c.ii. Ferritin> 800 ng / mL
  • 4.c.iii. Lymphocytes <800 cells / µL
  • 4.c.iv. PCR> 100 mg / L
  • 4.c.v. LDH> 500 U / L
  • 4.c.vi. IL-6> 15 pg / mL
  • 5. Direct or delegated verbal informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 36

排除标准

  • 1. Signs of active bleeding
  • 2. Immunosuppression by cancer or transplant
  • 3. Intolerance or allergy to AT or its components
  • 4. Pregnancy

研究者

发起方
Fundación para la Investigación Biomédica de Córdoba

相似试验

Study of antithrombin as prophylaxis of acute... | 临床试验